Mathew George, Philippe Paci, Timucin Taner, Departments of Surgery, Mayo Clinic, Rochester, MN 55905, United StatesTimucin Taner, Departments of Immunology, Mayo Clinic, Rochester, MN 55905, United States
Abstract:
This article reviews the current evidence and knowledge of progressive liver fibrosis after pediatric liver transplantation. This often-silent histologic finding is common in long-term survivors and may lead to allograft dysfunction in advanced stages. Surveillance through protocolized liver allograft biopsy remains the gold standard for diagnosis, and recent evidence suggests that chronic inflammation precedes fibrosis.